首页> 外文期刊>The Ochsner Journal >Building a Bridge Between Primary and Perioperative Care: Addressing the Challenges of Perioperative Buprenorphine Maintenance and Postdischarge Therapy
【24h】

Building a Bridge Between Primary and Perioperative Care: Addressing the Challenges of Perioperative Buprenorphine Maintenance and Postdischarge Therapy

机译:在初级和围手术期护理之间架起一座桥梁:应对围手术期丁丙诺啡维持和出院后治疗的挑战

获取原文
           

摘要

As awareness of the opioid use disorder epidemic has increased, the number of people on rehabilitative medication— assisted treatment has seen a concurrent rise. Buprenor- phine, available in multiple preparations, plays an important role in opioid detoxification, addiction therapy, and chronic pain management. Cizdol, Subutex, Suboxone, Zubsolv, and Bunavail are available as buprenorphine hydrochloride (HCl) alone or as a combination of buprenorphine and nal- oxone HCl and are typically used to treat opioid addiction. Temgesic is available as a sublingual tablet to treat moder- ate to severe pain. Buprenex is formulated as a solution for injection and is often used for acute pain in primary care set- tings. Norspan and Butrans are transdermal preparations used for management of chronic pain.
机译:随着人们对阿片类药物使用障碍流行病的认识增加,接受康复治疗(辅助治疗)的人数同时增加。丁丙诺啡有多种制剂,在阿片类药物排毒,成瘾疗法和慢性疼痛管理中起着重要作用。 Cizdol,Subutex,Suboxone,Zubsolv和Bunavail可单独使用盐酸丁丙诺啡(HCl),也可将丁丙诺啡与盐酸纳洛酮合用,通常用于治疗阿片类药物成瘾。 Temgesic可作为舌下片剂用于治疗中度至重度疼痛。 Buprenex配制成注射液,通常用于基层医疗机构的急性疼痛。 Norspan和Butrans是用于治疗慢性疼痛的透皮制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号